DoW Toxic Exposures Investigator Initiated Research Award

The Toxic Exposures Investigator-Initiated Research Award is administered by the Defense Health Agency through the Congressionally Directed Medical Research Programs as part of the Toxic Exposures Research Program. This program was initiated by Congress to address the growing need for research into adverse health outcomes associated with military-related toxic exposures affecting Service Members, Veterans, their families, and the broader public. The program reflects a federal commitment to improving health outcomes and quality of life through targeted research investments, with appropriations totaling over one hundred million dollars since its inception. The purpose of this funding opportunity is to support hypothesis-driven research that contributes meaningfully to the understanding, prevention, diagnosis, or treatment of diseases and conditions associated with toxic exposures in military contexts. Projects may span the full research spectrum, including basic laboratory work, translational studies, preclinical models, and clinical research that does not meet the definition of a clinical trial. Applicants are required to align their proposed research with at least one program goal, such as predicting and preventing exposure effects, improving diagnostics, or advancing treatment strategies, as well as one designated topic area including neurotoxin exposure, Gulf War Illness, airborne hazards, or other military-related toxic exposures. Funding under this opportunity is structured as grants with a maximum total cost of eight hundred thousand dollars per award over a performance period of up to three years. The program anticipates awarding approximately three grants from a total allocation of about two point four million dollars. Funds must be used in accordance with federal grant regulations, with allowable expenses including research activities and limited travel for collaboration or dissemination. However, costs associated with clinical trials are explicitly disallowed, and applicants must ensure that proposed activities adhere to all outlined restrictions and compliance requirements. Eligibility for this funding opportunity is broad and inclusive, allowing both domestic and international organizations to apply, including public and private institutions, nonprofit and for-profit entities, and intramural and extramural organizations. Principal Investigators must be independent researchers affiliated with an eligible organization, and individuals in mentored positions are not eligible to serve as the lead investigator. Cost sharing is not required, and awards are made to organizations rather than individuals. The application process consists of a mandatory two-step submission. Applicants must first submit a pre-application through the Electronic Biomedical Research Application Portal, which includes a concise narrative outlining the research hypothesis, study design, alignment with program goals, and anticipated impact. Based on this submission, selected applicants are invited to submit a full application through either eBRAP or Grants.gov, depending on organizational type. The full application requires detailed documentation, including a comprehensive project narrative, supporting materials, technical and lay abstracts, and additional compliance documentation. Applications are evaluated through a rigorous two-tier review process consisting of peer review and programmatic review. Peer review assesses scientific merit, feasibility, and methodological rigor, while programmatic review considers alignment with program priorities, portfolio balance, and overall impact. Key evaluation criteria include research strategy, feasibility, impact on military health, statistical analysis, and qualifications of the research team. Additional considerations include data sharing plans, budget appropriateness, and institutional support. The timeline for this opportunity includes a pre-application deadline in mid-August, followed by invitations to submit full applications in early October, and a final application deadline in mid-November. Peer review occurs in early the following year, with programmatic review shortly thereafter. Awards are expected to be finalized by late September of the following year, with funds available for use through several subsequent fiscal years. Applicants are encouraged to begin preparations early due to registration requirements and the complexity of submission materials.

Ensure strong alignment with program goals and topic areas; clearly demonstrate military relevance and impact; include robust preliminary data; avoid proposing clinical trials; follow all formatting and submission requirements strictly